Items related to Cancer Immunology and Immunotherapy (Current Topics...

Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344) - Softcover

 
9783642267888: Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344)
View all copies of this ISBN edition:
 
 
Cancer Immunotherapy discusses tumor-immune interactions in several human cancers. The text proposes an integrated scheme of the impact of local immune reactions on clinical outcome, and illustrates various aspects of this complexity.

"synopsis" may belong to another edition of this title.

From the Back Cover:
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that usher in a new era of cancer immunotherapy. These “first-in-class” treatments reflect the substantive progress that basic and translational scientists have made towards understanding the mechanisms underlying protective tumor immunity in cancer patients Immunotherapies were first explored at the turn of the twentieth century, but the crafting of potent treatments required more detailed knowledge of how the immune system responds to cancer. Advances in genetic, cellular, and biochemical technologies have begun to yield this critical information, focusing attention on immune recognition, regulation, and escape. Indeed, the dynamic interplay of these processes in the tumor microenvironment is now recognized to play a decisive role in determining disease outcome. This volume highlights the rapid progress and breadth of research in cancer immunology, and provides a framework for anticipating many more clinical successes in cancer immunotherapy.
Review:

From the reviews:

“This book comprises 13 reviews, contributed by members of a cross-section of groups working in the ... field of cancer immunology. ... this book is at its best when considering small and apparently discrete topics ­­– its strength comes from being able to read all of these ideas on one place. ... Overall, this book gives a thorough and detailed overview of the current state of basic and translational research into cancer immunology ... . It’s probably most appropriate for researchers ... .”­­­ (Victoria Lawson, Immunology News, November, 2011)

"About this title" may belong to another edition of this title.

  • PublisherSpringer
  • Publication date2013
  • ISBN 10 3642267882
  • ISBN 13 9783642267888
  • BindingPaperback
  • Number of pages320
  • EditorDranoff Glenn

Other Popular Editions of the Same Title

9783642141355: Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344)

Featured Edition

ISBN 10:  3642141358 ISBN 13:  9783642141355
Publisher: Springer, 2011
Hardcover

Top Search Results from the AbeBooks Marketplace

Seller Image

Published by Springer (2013)
ISBN 10: 3642267882 ISBN 13: 9783642267888
New Soft Cover Quantity: 1
Seller:
booksXpress
(Bayonne, NJ, U.S.A.)

Book Description Soft Cover. Condition: new. Seller Inventory # 9783642267888

More information about this seller | Contact seller

Buy New
US$ 208.89
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds
Stock Image

Published by Springer (2013)
ISBN 10: 3642267882 ISBN 13: 9783642267888
New Softcover Quantity: > 20
Seller:
Lucky's Textbooks
(Dallas, TX, U.S.A.)

Book Description Condition: New. Seller Inventory # ABLIING23Mar3113020222666

More information about this seller | Contact seller

Buy New
US$ 229.98
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds
Seller Image

Dranoff, Glenn
Published by Springer Berlin Heidelberg (2013)
ISBN 10: 3642267882 ISBN 13: 9783642267888
New Softcover Quantity: > 20
Print on Demand
Seller:
moluna
(Greven, Germany)

Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tu. Seller Inventory # 5054833

More information about this seller | Contact seller

Buy New
US$ 198.42
Convert currency

Add to Basket

Shipping: US$ 52.41
From Germany to U.S.A.
Destination, rates & speeds
Stock Image

Glenn Dranoff
Published by Springer (2013)
ISBN 10: 3642267882 ISBN 13: 9783642267888
New Softcover Quantity: > 20
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)

Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783642267888_lsuk

More information about this seller | Contact seller

Buy New
US$ 242.45
Convert currency

Add to Basket

Shipping: US$ 12.47
From United Kingdom to U.S.A.
Destination, rates & speeds
Seller Image

Glenn Dranoff
ISBN 10: 3642267882 ISBN 13: 9783642267888
New Taschenbuch Quantity: 2
Print on Demand
Seller:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Germany)

Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment. 320 pp. Englisch. Seller Inventory # 9783642267888

More information about this seller | Contact seller

Buy New
US$ 235.80
Convert currency

Add to Basket

Shipping: US$ 24.61
From Germany to U.S.A.
Destination, rates & speeds
Stock Image

Published by Springer (2013)
ISBN 10: 3642267882 ISBN 13: 9783642267888
New Softcover Quantity: 4
Seller:
Books Puddle
(New York, NY, U.S.A.)

Book Description Condition: New. pp. 320. Seller Inventory # 2648033154

More information about this seller | Contact seller

Buy New
US$ 261.99
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds
Seller Image

Glenn Dranoff
Published by Springer Berlin Heidelberg (2013)
ISBN 10: 3642267882 ISBN 13: 9783642267888
New Taschenbuch Quantity: 1
Seller:
AHA-BUCH GmbH
(Einbeck, Germany)

Book Description Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment. Seller Inventory # 9783642267888

More information about this seller | Contact seller

Buy New
US$ 239.11
Convert currency

Add to Basket

Shipping: US$ 35.29
From Germany to U.S.A.
Destination, rates & speeds
Stock Image

Published by Springer (2013)
ISBN 10: 3642267882 ISBN 13: 9783642267888
New Softcover Quantity: > 20
Seller:
California Books
(Miami, FL, U.S.A.)

Book Description Condition: New. Seller Inventory # I-9783642267888

More information about this seller | Contact seller

Buy New
US$ 283.00
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds
Stock Image

Published by Springer (2013)
ISBN 10: 3642267882 ISBN 13: 9783642267888
New Softcover Quantity: 4
Print on Demand
Seller:
Majestic Books
(Hounslow, United Kingdom)

Book Description Condition: New. Print on Demand pp. 320. Seller Inventory # 44782173

More information about this seller | Contact seller

Buy New
US$ 289.51
Convert currency

Add to Basket

Shipping: US$ 8.12
From United Kingdom to U.S.A.
Destination, rates & speeds
Stock Image

Dranoff, Glenn (Editor)
Published by Springer (2013)
ISBN 10: 3642267882 ISBN 13: 9783642267888
New Paperback Quantity: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)

Book Description Paperback. Condition: Brand New. 2011 edition. 320 pages. 9.10x6.10x0.90 inches. In Stock. Seller Inventory # x-3642267882

More information about this seller | Contact seller

Buy New
US$ 287.03
Convert currency

Add to Basket

Shipping: US$ 12.49
From United Kingdom to U.S.A.
Destination, rates & speeds